About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Nashville | 754 Studies

Clinical Trials Breast CancerNashville

Breast Cancer Clinical Trials in Nashville

Find 754 clinical trials for breast cancer near Nashville, Tennessee. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 754 trials

TerminatedT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantRATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors predict whether patients undergoing donor stem cell transplant will develop acute…NCT00651716·Nashville, Tennessee UnknownPhase I Study of Pyrotinib in Patients With HER2-positive Solid TumorsPart 1: to assess the safety and tolerability of pyrotinib and to define the maximum tolerated dose (MTD) of pyrotinib in patients with Human Epidermal Growth Factor Receptor 2…NCT02500199·Orange, California and 9 others CompletedA Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerThe main purpose of this study is to learn if adding bevacizumab to standard treatment with chemotherapy (docetaxel, doxorubicin, and cyclophosphamide) for early stage…NCT00887536·Bessemer, Alabama and 532 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedPilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast CancerThis is a pilot "window of opportunity" clinical study in patients with operable breast cancer investigating use of reparixin as single agent in the time period between clinical…NCT01861054·Indianapolis, Indiana and 8 others

RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive…NCT07062965·Chandler, Arizona and 201 others

Active not recruitingTrastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]This study will compare DS-8201a to physician choice standard treatment. Participants must have HER2-low breast cancer that has been treated before.NCT03734029·Chandler, Arizona and 207 others

TerminatedGW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerThis study was designed to be two-part study (Phase I/Phase II). Part I was designed to find the optimal (best) doses of GW572016, docetaxel, and trastuzumab when given together.NCT00251433·Nashville, Tennessee and 4 others

CompletedSafety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast CancerThe purpose of this study is to determine the safety, tolerability and pharmacokinetics of enzalutamide alone and in combination with anastrozole, or exemestane, or fulvestrant in…NCT01597193·Aurora, Colorado and 16 others

CompletedA Study of ZN-c5 in Subjects With Breast CancerThis is a Phase 1/2, open-label, multicenter, dose-escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZN-c5…NCT03560531·Tucson, Arizona and 37 others

TerminatedA Study to Investigate LYL797 in Adults With Solid TumorsThis study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer…NCT05274451·Scottsdale, Arizona and 17 others

CompletedA Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerThis is a 3 arm Phase 3 study to evaluate the safety and efficacy of the addition of veliparib plus carboplatin versus the addition of carboplatin to standard neoadjuvant…NCT02032277·Scottsdale, Arizona and 157 others

Active not recruitingSafety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®The purpose of this trial is to assess the safety and efficacy of the Xoft Axxent eBx System when used for single-fraction IORT in early stage breast cancer.NCT01644669·Tucson, Arizona and 23 others

TerminatedA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsThe purpose of the trial is to evaluate the safety, determine the recommended Phase 2 dose (RP2D), and assess preliminary clinical activity of GEN1044 in patients with solid…NCT04424641·Nashville, Tennessee and 5 others

TerminatedPhase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast CancerThe primary objective of Phase 1b will be to evaluate the safety and tolerability of TTI-101 when added to palbociclib and AI or fulvestrant administered orally to participants…NCT05384119·Fort Lauderdale, Florida and 5 others

CompletedDrug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast CancerThe purpose of this study is to determine the effect of exemestane on the pharmacokinetics (PK) of entinostat and to determine the effect of entinostat on the PK of exemestane in…NCT02820961·Denver, Colorado and 2 others

CompletedA Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryThis trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with estrogen receptor positive/ human epidermal growth factor receptor 2…NCT05549505·Springdale, Arkansas and 48 others

CompletedFolate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast CancerThis Phase II trial evaluates the safety and immunogenicity of two doses of the Folate Receptor Alpha (FRα) peptide vaccine mixed with GM-CSF as a vaccine adjuvant, with or…NCT02593227·Tampa, Florida and 10 others

TerminatedA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionThe primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.NCT05325866·Duarte, California and 114 others

TerminatedMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell…NCT00089141·Duarte, California and 15 others

TerminatedStudy of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast CancerEvaluate the safety and tolerability and determine the maximum tolerated dose (MTD) of the combination of tesevatinib and trastuzumab in subjects with HER2-positive metastatic…NCT02154529·La Jolla, California and 5 others

PreviousPage 3 of 38Next

Other Conditions in Nashville

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma